Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 11;12(3):264-272.
doi: 10.4103/tjo.tjo_55_21. eCollection 2022 Jul-Sep.

The current clinical role of optical coherence tomography angiography in neuro-ophthalmological diseases

Affiliations
Review

The current clinical role of optical coherence tomography angiography in neuro-ophthalmological diseases

Serdar Bilici et al. Taiwan J Ophthalmol. .

Abstract

After the revolutionary effect of optical coherence tomography (OCT) on ophthalmology practice, recent OCT-based technology OCT angiography (OCT-A) also has rapidly gained a wide clinical acceptance. OCT-A is a noninvasive, depth-resolved imaging tool for the evaluation of retinal vascular changes. Since its introduction, the understanding of retinal vascular diseases, pacychoroid spectrum diseases, and other diseases have been enriched in many ways. More importantly, OCT-A provides depth-resolved information that has never before been available. The whole spectrum of neuro-ophthalmological diseases shows consistent peripapillary and macular capillary changes with structural and functional correlation. The superficial and deeper retinal and choroidal vasculatures are affected depending on the nature of the disease process. Therefore, OCT-A play an important role in the diagnosis and management of optic nerve-related diseases as well. In this review, we summarized existing literature on the use of OCT-A in neuro-ophthalmological diseases such as arteritic anterior ischemic neuropathy, nonarteritic anterior ischemic neuropathy, papillitis, papilledema, multiple sclerosis. Currently, OCT-A has an important position as a useful, noninvasive tool in the evaluation of neuro-ophthalmologic diseases; however, OCT-A has several limitations regarding its technical capabilities in challenging neuro-ophthalmic cases. With the improvement in the technical capacity of OCT-A, it will have a more important place in the diagnosis and follow-up of neuro-ophthalmological diseases in future.

Keywords: Anterior ischemic optic neuropathy; multiple sclerosis; optic nerve head optical coherence tomography angiography; optical coherence tomography angiography; papilledema.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interests of this paper.

Similar articles

Cited by

References

    1. Lee J, Bosen RB. Learning to read retinal OCT. Ophthalmol Manage. 2015;19:4446–8.
    1. Potsaid B, Baumann B, Huang D, Barry S, Cable AE, Schuman JS, et al. Ultrahigh speed 1050nm swept source/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second. Opt Express. 2010;18:20029–48. - PMC - PubMed
    1. Coscas G, Lupidi M, Coscas F. Heidelberg spectralis optical coherence tomography angiography: Technical aspects. In: Bandello F, Souied EH, Querques G, editors. OCT Angiography in Retinal and Macular Diseases. Vol. 56. Dev Ophthalmol, Basel: Karger; 2016. pp. 1–5. - PubMed
    1. Turgut B. Optical coherence tomography angiography – A general view. Eur Ophthalmic Rev. 2016;10:39–42.
    1. Richard G, Soubrane G, Yannuzzi LA. Textbook and Atlas. 2nd. Stuttgart, Germany: Theime Medical Publishers; 1998. Fluorescein and ICG Angiography.